FindTrial
Sign In

Measurement of Biomarkers of Neurodegeneration in Newborns After Exposure to Anesthetics

Measurement of Biomarkers of Neurodegeneration in Newborns After Exposure to Anesthetics

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-15007163
Enrollment
Unknown
Registered
2015-09-01
Start date
2015-10-07
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anesthetics-induced neurodegeneration

Interventions

1:System anesthesia procedures
2:Spinal canal anesthesia procedures

Sponsors

Shanghai First Matanity andInfant Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1) Women delivering a child via cesarean section; 2) Informed consent.

Exclusion criteria

Exclusion criteria: 1) Known fetal neurologic defect; 2) Known maternal neurologic abnormality; 3) Sensitivity or allergy to medications used in the study.

Design outcomes

Primary

MeasureTime frame
S100 beta protein;—

Secondary

MeasureTime frame
concentration of S100 beta in maternal amniotic fluid;The umbilical venous andarterial blood gas results;The concentration of S100 beta in maternal blood;—

Countries

CHINA

Contacts

Public ContactZhiqiang Liu
drliuzhq@hotmail.com+86 13816877756

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026